ACI’s Sixth National Conference on…

September 18-20, 2006 • Palo Alto, CA

Adding, Updating and Expanding

COMPREHENSIVE CANCER
PROGRAMS AND SERVICES
For Hospitals and Health Systems
INCLUDES SITE TOUR OF THE STANFORD HOSPITAL AND CLINICS
A National Oncology Conference Focused on Exploring The Latest Developments For Managing A More Competitive and
Comprehensive Cancer Program to Increase Patient Volume, Improve Outcomes and Excel in Total Patient Cancer Care.
Gain Knowledge From Experts on the Opportunities to Add and Expand Oncology Services to Better Detect, Diagnose and
Treat Cancer. Explore Techniques to Better Equip Cancer Centers with the Latest Advancements in Medical Technology
through Real Case Studies, Research Findings and Organizational Models from Renowned Cancer Institutes.

WHAT WILL BE DISCUSSED DISTINGUISHED SPEAKING FACULTY INCLUDE

• Comprehensive Cancer Centers: Obstacles to a
successful business model
• Improving the delivery of cancer patient care, through the
streamlining and integration of medical programs, staff, and resources
for more efficient and cost effective clinical operations
• Meeting the challenges of oncology care including: increased
demand for services, staff and high-priced technologies
• Providing timely and cost effective treatment through advanced
combined multiple imaging technologies including: PET/CT scanner
Karyn A. Goodman, M.D., Assistant Professor, Department of
Radiation Oncology, Stanford Cancer Center
Shalom Kalnicki, M.D., F.A.C.R.O, Professor and Chairman,
Department of Radiation Oncology, Montefiore Medical Center,
Albert Einstein College of Medicine, NY
David Cheng, MD, PhD, Clinical Chief, Nuclear Medicine, Yale-
New Haven Hospital / Yale Cancer Committee, CT
Sarah C. Lilly, MD, Integrative Medicine, Memorial Sloan-
Kettering Cancer Center, NY

• Emerging trends and the impact of technology on your oncology
program: advancements in early detection, PET/CT, molecular
imaging, image guided radiation therapy, proton therapy,
chemotherapy and more
• Successfully marketing your oncology services to the community to
increase patient recruitment, revenue, and competitive advantage
• Developing hospital partnerships to increase patient access to
clinical trials, services and best practices
• Structuring multi-disciplinary teams to increase patient focus, provide
comprehensive treatment options and improve outcomes
• Designing a patient friendly cancer center to accommodate
increased staff, services, and future growth
• Implementing outpatient service programs to increase patient
convenience, satisfaction and quality of life
IN ASSOCIATION WITH:
Joanne MacIsaac, Principal/Vice President, Interior Design, TRO/
The Ritchie Organization
Laura Baynham-Fletcher, MA, LPC, Director, Place of wellness,
Integrative Medicine Program, The University of Texas, M. D.
Anderson Cancer Center, TX
Lennie Sender, MD, Deputy Clinical Director, UCI Chao Family
Comprehensive Cancer Center (UC Irvine)
Ira Goodman, Associate Director for Administration, Rebecca
and John Moores University of California, San Diego (UCSD)
Cancer Center
Peg OʼGrady, RN, MSN, OCN, Director of Care Management
and Operations, Fox Chase Cancer Center, Fox Chase Network
Division, PA
Ogan Gurel, MD MPHIL, CEO, Duravest, Inc., and Chairman,
Aesis Research Group LLC
Adjunct Professor, Roosevelt University
Nina J. Pickett, M.H.A. Administrator Department of Pediatrics
Memorial Sloan-Kettering Cancer Center
James May, AIA Director of Operations Granary Associates
 Adding, Updating and Expanding
COMPREHENSIVE CANCER PROGRAMS AND SERVICES
For Hospitals and Health Systems
PRE-CONFERENCE WORKSHOP: SEPTEMBER 18, 2006

2:00 PM – 4:00 PM HOSPITAL-BASED VERSUS COMMUNITY-BASED CANCER CENTERS:

HOW MEDICARE REIMBURSEMENT CHANGES THEIR RELATIONSHIPS
• The Changing Face of Part A Versus Part B Medicare Reimbursement in Oncology
• Trends in Drug Payment
• Trends in Protocol Payment for Common Regimens
• Cognitive Payment and Its Importance
• Why Community Practices Are Sending Hospitals Their Patients
• Why Community Practices Might Want to Sell You Their Clinic: Should You Buy?
• Conclusion: Is this The War On Cancer Patients?
Roberta L. Buell is a Principal in Sausalito Healthcare Partners and a consultant in Oncology Reimbursement

DAY 1: SEPTEMBER 19, 2006

7:20 AM REGISTRATION, CONTINENTAL BREAKFAST AND EXHIBITS

7:50 AM CHAIRPERSON’S WELCOMING REMARKS
Ogan Gurel, MD MPHIL
CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC
Adjunct Professor, Roosevelt University

8:00 AM DELIVERING MULTIDISCIPLINARY THERAPY FOR GI CANCER PATIENTS: CASE STUDY

OF IMAGE –GUIDED RADIOTHERAPY TO BETTER TARGET TUMORS

This presentation focus on the use of novel imaging and radiotherapy delivery techniques to allow for more targeted therapy of
upper GI tumors and are allowing for new attempts to dose escalate radiotherapy.
• The treatment of gastrointestinal cancers requires a multidisciplinary approach, combining the care of medical
oncologists, radiation oncologists, surgeons, and oncology nurses.
• Many upper GI cancers, including pancreas and esophageal tumors have not responded well to conventional treatments.
• Newer imaging radiation therapy delivery techniques may allow for better targeting of tumors and use of higher
radiotherapy doses with the goal of improving local control of upper GI tumors.
Karyn A. Goodman, M.D., Assistant Professor,
Department of Radiation Oncology,
Stanford Cancer Center
9:00 AM EMERGING TECHNOLOGY TRENDS IMPACTING CANCER CARE

• New technologies on the horizon

• Outlining the impact on both inpatient and outpatient oncology programs
• Operational and Financial strategies for preparing for these technology changes

Ogan Gurel, MD MPHIL

CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC
Adjunct Professor, Roosevelt University

10:00 AM MORNING REFRESHMENT BREAK

 Adding, Updating and Expanding
COMPREHENSIVE CANCER PROGRAMS AND SERVICES
For Hospitals and Health Systems
10:30 AM THE ROLE OF INNOVATIVE RADIATION TECHNOLOGIES IN
THE MODERN ACADEMIC CANCER CENTER
This presentation will address new modalities in radiation oncology and their applications in clinical trials, multidisiciplinary cancer
management and academic cancer program development. The future directions for radiation oncology will be discussed. Additionally,
the role of translational research, targeted therapies and laboratory advances in radiation technologies will be addressed.
Attendees will learn how to:
• Understand new radiation technology deployment in academic settings
• Review translational research programs as they relate to radiation oncology
• Plan for future radiation oncology program development in an integrated cancer center model

Shalom Kalnicki, M.D., F.A.C.R.O, Professor and Chairman,

Department of Radiation Oncology, Montefiore Medical Center,
Albert Einstein College of Medicine, NY
11:30 AM HOW INTEGRATIVE MEDICINE ENHANCES CANCER CARE
Dr. Lilly will present the principles of integrative oncology, discuss effective complementary therapies and botanicals, and
comment on the collaboration between oncologists and integrative medicine experts in the research and clinical arena. The model
of the Memorial Sloan-Kettering Cancer Center Department of Integrative Medicine will be described.
Attendees will learn how to:
• Understand and define integrative oncology, complementary medicine and alternative medicince
• Learn the complementary therapies that benefit patients including acupuncture, massage, meditation, nutrition and fitness
• Understand how the MSKCC Program of Integrative Medicine enhances care of patients with cancer and is part of an
effective team approach to cancer care.
Sarah C. Lilly, MD, Integrative Medicine,
Memorial Sloan-Kettering Cancer Center, NY
12:30 PM CONFERENCE NETWORKING LUNCHEON
Lunchtime Presenter: Michael Saracen, Director, Product Marketing, Accuray Incorporated
Robotic Radiosurgery: Complementing Existing Radiation Therapy, IMRT Or IGRT programs
The CyberKnife Robotic Radiosurgery System is the worldʼs first and only radiosurgery system that utilizes intelligent robotics
to treat tumors anywhere in the body with sub-millimeter accuracy. The CyberKnife System treats patients in single or staged
(typically 2-5) sessions by delivering multiple beams of precisely directed radiation that converge upon the tumor while minimizing
injury to surrounding healthy tissue.
By enabling the treatment of extracranial tumors anywhere in the body that cannot be addressed with traditional radiosurgery
or radiation therapy systems, Robotic Radiosurgery attracts a new patient population to physiciansʼ practices and complements
existing radiation therapy, IMRT or IGRT programs.
1:45 PM THE ROLE OF INTEGRATIVE MEDICINE IN COMPREHENSIVE CANCER CARE:
BEST PRACTICES AND CHALLENGES
Ms. Baynham-Fletcher will present the three components of a comprehensive integrative medicine program and discuss
best practices and challenges in establishing a program with a focus on clinical delivery. Topics will include credentialing,
documentation, and quality assurance/outcome measures. The model of The University of Texas M. D. Anderson Cancer Centerʼs
Integrative Medicine Program will be described.
Attendees will learn how to:
• Understand the three components of an integrative medicine program.
• Discuss several best practices and challenges in the areas of credentialing, documentation, quality assurance/participant
satisfaction and outcomes, marketing, and funding in an integrative medicine clinic.
• Understand how the three components of UTMDACCʼs Integrative Medicine Program work collaboratively to create
programs to manage side effects and enhance quality of life for cancer patients; provide educational resources for patients,
public, and healthcare providers; and establish cutting-edge research as part of an effective approach to cancer care.
Laura Baynham-Fletcher, MA, LPC, Director, Place of wellness, Integrative Medicine Program,
The University of Texas, M. D. Anderson Cancer Center, TX
 Adding, Updating and Expanding
COMPREHENSIVE CANCER PROGRAMS AND SERVICES
For Hospitals and Health Systems

2:45 PM CREATING A MULTI USE CANCER CENTER BUILDING

UCSD had planned for a multi use cancer center building for over 20 years. In the late 1990ʼs the plan reached fruition with the
commitment incorporated in the Cancer Centerʼs NCI core grant application. The presentation translates the commitment to a
building into a reality. The presentation will discuss the program and financial planning and construction of a 270,000 sf clinic and
research building during the period 2001- 2005, the opening date of the building. It will cover the building objectives, financing,
design, space allocation methodology and combined hospital/medical school cultures. It will summarize the lessons learned.
Attendees will learn how to:
• Assemble a financial plan for a building
• Identify key building elements
• Assign research space
• Confront major logistical and cultural issues in creating a single hospital/ medical school building
Ira Goodman, Associate Director for Administration,
Rebecca and John Moores University of California,
San Diego (UCSD) Cancer Center
3:45 PM AFTERNOON REFRESHMENT BREAK
4:00 PM PANEL: COMPREHENSIVE CANCER CENTERS: OBSTACLES TO A
SUCCESSFUL BUSINESS MODEL
Sarah C. Lilly, MD
Ira Goodman, Associate Director for Administration
Laura Baynham-Fletcher, MA, LPC, Director

4:45 PM CHAIRPERSON’S CLOSING REMARKS, Q&A AND GENERAL QUESTIONS

Ogan Gurel, MD MPHIL
CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC
Adjunct Professor, Roosevelt University
5:00 PM – 6:00 PM STANFORD COMPREHENSIVE CANCER CENTER TOUR

DAY 2: SEPTEMBER 20, 2006

8:20 AM CONTINENTIAL BREAKFAST AND EXHIBITS

8:55 AM CHAIRPERSON’S OPENING REMARKS
Ogan Gurel, MD MPHIL
CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC
Adjunct Professor, Roosevelt University

9:00 AM MULTI-DISCIPLINARY DISEASE MANAGEMENT PROGRAMS:

HOW TO GROW REFERRALS AND RESEARCH
Due to the chronic nature of cancer care, institutions are struggling to develop best practices and streamlined patient care
coordination. Multi-disciplinary disease programs foster collaborative treatment design but also offer an individualized plan
of care to the patient. Fox Chase Network, a subsidiary corporation of Fox Chase Cancer Center, has assisted numerous
community partners in Pennsylvania and New Jersey to assess, plan and implement disease management programs in the
areas of breast, colon, lung and genitourinary cancers utilizing a multi-disciplinary team of experts at the community hospital
site and a Nurse Navigator as a coordinator for patient care. By developing these disease teams, patients receive individual
messaging regarding their disease specific needs (treatment options) as well as research initiatives they can participate in and
benefit from. Breast Cancer Nurse Navigators are trained at Fox Chase Cancer Center quarterly on such topics as research,
quality improvement, policy and procedure development, education tools, utilization of National Comprehensive Cancer Network
guidelines for care and other best practice, evidence based methodologies. This Network partnership provides outreach of
research and best practice yielding increased patient volumes in these multidisciplinary programs.
Attendees will learn:
• Verbalize an understanding of solid tumor multi-disciplinary programs in cancer product lines.
 Adding, Updating and Expanding
COMPREHENSIVE CANCER PROGRAMS AND SERVICES
For Hospitals and Health Systems

• Describe the Nurse Navigator role in disease management development.

• Define how the multidisciplinary program process contributes to the referral and research growth at community and
comprehensive cancer centers.
Peg OʼGrady, RN, MSN, OCN,
Director of Care Management and Operations, Fox Chase Cancer Center,
Fox Chase Network Division, PA
10:00 AM THE ROLE OF NUCLEAR MEDICINE IN MANAGEMENT OF ONCOLOGY PATIENTS
Dr. Cheng will give an overview of the field of nuclear medicine in relation to oncology patients, including diagnostic, staging, and treatments.
Attendees will learn how to:
• What is Nuclear Medicine
• What is the diagnostic role of Nuclear Medicine for oncology patients
• What is the therapeutic role of Nuclear Medicine for oncology patients
David Cheng, MD, PhD, Clinical Chief, Nuclear Medicine,
Yale-New Haven Hospital / Yale Cancer Committee, CT
11:00 AM MORNING REFRESHMENT BREAK
11:30 AM DESIGNING A PATIENT AND FAMILY FOCUSED CANCER CENTER WHILE
MANAGING FUTURE GROWTH
• A case study from the Department of Pediatric Oncology at Memorial Sloan-Kettering Cancer Center
• Data and strategies shared will be applicable for all types of cancer centers.
• This informative session will address ways to successfully market oncology services to the community with a focus on
improving competitive advantage, branding, patient recruitment and revenue.
Nina J. Pickett, M.H.A. Administrator Department of Pediatrics
Memorial Sloan-Kettering Cancer Center
James May, AIA Director of Operations Granary Associates
12:30 PM CONFERENCE NETWORKING LUNCHEON
Lunchtime Presenter: Corey Zankowski, PhD, Sr Director of Software Systems Marketing, Varian Medical Systems
Managing oncology information in an integrated department
• clinical drivers
• operational efficiencies
• connectivity from the enterprise to the devices
• as an enabler for new capabilities
1:30 PM SUCCESSFULLY IMPLEMENTING NEW AND COST EFFECTIVE ADOLESCENT AND
YOUNG ADULT CANCER SERVICES
An overview of the special multi-disciplinary team approach needed for patients 0 to 30 years of age that are too old to be treated
with pediatric regimens and too young to be treated with adult regimens.
Lennie Sender, MD,
Deputy Clinical Director,
UCI Chao Family Comprehensive Cancer Center (UC Irvine)
2:30 PM SUSTAINABILITY, PATIENT BUILDINGS AND THE ENVIRONMENT
Case study of 50,000 square foot LEED Silver-certified freestanding comprehensive cancer center in Augusta, Maine
Attendees will learn how to:
• Consolidation of two separate programs and how the process can be used as an opportunity for collaboration
• Exploration of best practices of other services industries and how to use them as a catalyst for change
• Master planning of a Greenfield site, allowing for further growth, with cancer center as the first phases
• How a LEED-certification can provide enhanced marketability
Joanne MacIsaac, Principal/Vice President,
Interior Design, TRO/The Ritchie Organization
 Adding, Updating and Expanding
COMPREHENSIVE CANCER PROGRAMS AND SERVICES
For Hospitals and Health Systems

3:30 PM CHAIRPERSON’S CLOSING REMARKS, Q&A AND GENERAL QUESTIONS

Ogan Gurel, MD MPHIL

CEO, Duravest, Inc., and Chairman, Aesis Research Group LLC
Adjunct Professor, Roosevelt University

3:40 PM END OF CONFERENCE

Dear Healthcare Executive:
The prognosis for cancer centers has improved with business diversification, financial restructuring and reorganization of
resources. These paradigm shifts have strategically placed oncology center programs and services at the forefront of consumer
preferences. Oncology is the number one service for which patients will travel and pay a premium to attain exceptional care.
Due to the dynamic nature of the oncology community, continuing professional development for healthcare providers is not only
necessary but essential.
ACI will bring together leading hospital executives, physicians, nurse administrators and individuals involved in the care of cancer
patients. The two-day symposium will focus on developing and effectively managing more competitive and comprehensive
hospital cancer programs and adding or expanding oncology services to better detect, diagnose and treat cancer. Procure
knowledge of case studies, research findings and successful organizational models from leading national oncology programs.
Conference presenters from various sectors of the field will share their best practice models and comprehensive analysis of
current programs and services.
Register today for this unique networking and informational opportunity to develop tools and maximize the potential of your cancer center.

WHO WILL ATTEND

The conference is ideally suited for physicians, nurses, administrators and other health professionals involved in the care of
cancer patients – Representing Community Hospitals, Health Systems, Academic Medical Centers, Hospital Networks, Medical
Laboratories and Comprehensive Cancer Centers. Director of Oncology Services. The conference is also well suited for physician
leaders managing departments of: Medical Oncology, Clinical Oncology, Radiation Oncology, Multidisciplinary Oncology, Surgical
Oncology and other specialized areas of oncology.

CONFERENCE VENUE
TBD

HOTEL & AIRFARE

TBD
For special rates, call United Airlines at 1-800-521-4041 and mention ID code 556FA for discounted airfares.
Take advantage of Special Conference Rates!

CONFERENCE FEES AND REGISTRATION

Conference Fee: $1,995*

Conference Documentation CD: $615

Conference+Workshop: $2,390*

(Documentation CD includes copies of all proceedings on CD and shipping is included)

REGISTER 3 & GET 1 FREE!

Any organization registering three persons at the same time will be entitled to a fourth registrant FREE of charge!

For larger groups call (414) 221 1700

PAYMENT: ACI must recieve payment 5 days after receiving booking form.